Beacon Biosignals raises $27M to scale EEG, AI-based neurobiomarker discovery platform

By SharpBrains | November 17, 2021

Neu­rotech start­up Bea­con Biosig­nals scores $27M to bring AI to EEG analy­sis (Med­C­i­ty News): Elec­troen­cephalog­ra­phy is a decades-old tech­nique for cap­tur­ing brain activ­i­ty, data that are used to eval­u­ate brain dis­or­ders. Bea­con Biosig­nals is apply­ing arti­fi­cial intel­li­gence to these tests, and the neu­rotech­nol­o­gy start­up has found a ready mar­ket in phar­ma­ceu­ti­cal com­pa­nies inter­est­ed in assess­ing how…

Read More

Next: Analyzing typing speed, speech and sleep patterns to identify cognitive decline, dementia, Parkinson’s, and more

By SharpBrains | November 19, 2020

AI May Help Iden­ti­fy Patients With Ear­­ly-Stage Demen­tia (The Wall Street Jour­nal): Researchers are study­ing whether arti­­fi­­cial-intel­li­­gence tools that ana­lyze things like typ­ing speed, sleep pat­terns and speech can be used to help clin­i­cians bet­ter iden­ti­fy patients with ear­­ly-stage dementia.

Read More

Latest brain research, tools and teasers to think outside the mental health status quo box

By SharpBrains | February 26, 2020

__ Time for a new edi­tion of Sharp­Brains’ e‑newsletter, fea­tur­ing a range of  research find­ings, resources, brain teasers and rid­dles to help trans­late emerg­ing neu­ro­science into real-world appli­ca­tions and improve our col­lec­tive brain & men­tal health. New think­ing: Neu­ro­science tips about grat­i­tude, aging, pain and the brain: An inter­view with Dr. Daniel Lev­itin What’s normal?…

Read More